We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

Bayer Q1 Earnings Beat Estimates, Crop Science Unit Hurts Sales

Bayer AG BAYRY reported first-quarter 2025 core earnings of 66 cents per American Depositary Receipt (ADR), beating the Zacks Consensus Estimates of 63 cents. The company reported earnings of 77 cents per ADR in the year-ago quarter. Core earnings of €2.49 per share deteriorated …

EODHD | 13 May 2025

Wall Street Analysts Believe Intapp (INTA) Could Rally 26.09%: Here's is How to Trade

Shares of Intapp (INTA) have gained 7.3% over the past four weeks to close the last trading session at $56.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going …

EODHD | 13 May 2025

Does Kemper (KMPR) Have the Potential to Rally 25.46% as Wall Street Analysts Expect?

Shares of Kemper (KMPR) have gained 12.8% over the past four weeks to close the last trading session at $65.52, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going …

EODHD | 13 May 2025

Wall Street Analysts Predict a 36.55% Upside in Ardent Health Partners, Inc. (ARDT): Here's What You Should Know

Ardent Health Partners, Inc. (ARDT) closed the last trading session at $14.83, gaining 19.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean …

EODHD | 13 May 2025

Wall Street Analysts Believe BridgeBio Pharma (BBIO) Could Rally 63.87%: Here's is How to Trade

BridgeBio Pharma (BBIO) closed the last trading session at $35.68, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …

EODHD | 13 May 2025

Here's Why Astellas Pharma (ALPMY) Is a Great 'Buy the Bottom' Stock Now

Shares of Astellas Pharma Inc. (ALPMY) have been struggling lately and have lost 7% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract …

EODHD | 13 May 2025

After Golden Cross, Telefonica Brasil (VIV)'s Technical Outlook is Bright

Telefonica Brasil S.A. (VIV) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VIV's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross." Considered an important …

EODHD | 13 May 2025

Here's Why Investors Should Consider Retaining Xylem Stock Now

Xylem Inc. XYL is witnessing strength in the Measurement & Control Solutions segment, driven by robust demand for advanced technology solutions like smart metering and other applications. Growth in the transport application business, driven by the increased infrastructure projects in the United States, is …

EODHD | 13 May 2025

Energean (LON:ENOG) shareholder returns have been splendid, earning 101% in 5 years

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the market average. And in our experience, buying the right stocks can give your wealth a significant boost. To wit, the Energean share price has …

EODHD | 13 May 2025

Evolus, Inc. (EOLS): A Bull Case Theory

We came across a bullish thesis on Evolus, Inc. (EOLS) on Substack by Greg ┃The Elevator Pitch. In this article, we will summarize the bulls’ thesis on EOLS. Evolus, Inc. (EOLS)'s share was trading at $11.76 as of May 7th. EOLS’s forward P/E was …

EODHD | 13 May 2025
Support

Hi! How can we help you today?

Loading…